Sunday, June 8, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Valley of Forgetting review: Moving story reveals hidden human cost of drug trials

April 2, 2025
in Health News
Share on FacebookShare on Twitter


YARUMAL, - AUGUST 18 - Alirio sits in his living room with his son Alexis, 6, snuggles in and his wife Marta. Alirio, 42, is a coffee farmer who is also a participant in the University of Antioquia study who lives near Yarumal. The study, lead by Dr. Francisco Lopera, a behavioural neurologist at Medellin's University of Antioquia, researches a local family tree with a genetic mutation that causes early-onset Alzheimer's disease. The Colombian family's genetic curse may be the world's best hope for an Alzheimer's cure. In that family tree researchers have the perfect group to study the disease and have now begin a clinical trial to see if they have a medication that might be able to delay onset. in Medellin. (Steve Russell/Toronto Star via Getty Images)

Alirio, a coffee farmer and participant in the Medellín Alzheimer’s drug trials

Steve Russell/Toronto Star via Getty Images

Valley of Forgetting
Jennie Erin Smith (Riverhead Books)

After working in health journalism for over 10 years, I have covered countless drug trials – some runaway successes, others out-and-out failures, and everything in between. But I am ashamed to admit that I have rarely considered how these highs and lows affect the people involved.

In Valley of Forgetting: Alzheimer’s families and the search for a cure, journalist Jennie Erin Smith puts them in the spotlight in her story of a…



Source link : https://www.newscientist.com/article/mg26635373-800-a-moving-story-reveals-hidden-human-cost-of-drug-trials/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

Author :

Publish date : 2025-04-02 18:00:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

Healthcare-Related Harm Affects One in 10 NHS Patients

Next Post

AI Chatbot Helps Mental Health; Neuroplastogen for PTSD: Magic Mushroom Dispensaries

Related Posts

Health News

Pegcetacoplan Maintains Kidney Benefits at 52 Weeks

June 8, 2025
Health News

A Study Linked GLP-1 Drugs to What Ocular Condition?

June 7, 2025
Health News

Novel IgA Nephropathy Injectable Halved Proteinuria

June 7, 2025
Health News

Politics a Star Player at the AMA House of Delegates Opening Session

June 7, 2025
Health News

CAR-T for Solid Tumors; Blood Test for Colon Cancer

June 7, 2025
Health News

Limited Survival Benefit With Expanded Kidney Donor Criteria

June 7, 2025
Load More

Pegcetacoplan Maintains Kidney Benefits at 52 Weeks

June 8, 2025

A Study Linked GLP-1 Drugs to What Ocular Condition?

June 7, 2025

Novel IgA Nephropathy Injectable Halved Proteinuria

June 7, 2025

Politics a Star Player at the AMA House of Delegates Opening Session

June 7, 2025

CAR-T for Solid Tumors; Blood Test for Colon Cancer

June 7, 2025

Limited Survival Benefit With Expanded Kidney Donor Criteria

June 7, 2025

Mass Screenings Alone Won’t Control the U.S. Hypertension Problem

June 7, 2025

Can TikTok’s Coke and Fries ‘Cure’ Treat a Migraine?

June 7, 2025
Load More

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version